CFLAR and glioblastoma: In agreement with the central role of Caspase-8 in this pathway, several studies highlight that TRAIL sensitivity in glioblastoma is tightly dependent on the expression levels of Caspase-8 or on the expression levels or activity of the modulators of its apoptotic activation such as FLIP proteins ([67,73]).